human isogenic cell lines Horizon Discovery to Support Blueprint Medicines' Cancer Research Platform NEW YORK (GenomeWeb News) – Horizon Discovery announced today a research service agreement to deploy its X-MAN isogenic cell lines in support of Blueprint Medicine's "New Targets" discovery platform. Horizon, UCL Collaborate on Huntington's Disease Research NEW YORK (GenomeWeb News) – Horizon Discovery said today it has entered into a research collaboration covering gene editing with the Institute of Neurology, University College London. Crown Bioscience Collaborates with Horizon on X-MAN Cell Lines NEW YORK (GenomeWeb News) – Crown Bioscience and Horizon Discovery today announced that they will partner on offering new in vivo X-MAN models as a service to Crown's customers. Horizon Discovery Establishes Center of Excellence at Washington University NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has established a Center of Excellence at Washington University in St. Louis. Horizon Discovery, ATCC Sign Distribution Deal for Cell Lines NEW YORK (GenomeWeb News) – Horizon Discover today said it has signed a licensing and distribution deal with the American Type Culture Collection for certain sets of panels of X-Man isogenic cell lines. Jul 9, 2012 Horizon to Use Genome Editing Technology to Support Bayer Pharma Cancer R&D Programs Apr 30, 2012 Horizon, H3 Biomedicine Partner on Cancer Drug Targets Mar 12, 2012 Horizon Discovery, RFUMS Collaborate on Disease Model of Cystic Fibrosis Nov 21, 2011 Horizon Inks Deals with NCI, NHGRI Nov 7, 2011 Horizon Discovery, Promega Partner on Predictive Human Disease Models Aug 31, 2011 Horizon Licenses Virology X-Man Cell Lines from University of Minnesota Jun 30, 2011 Horizon Secures Distribution Rights to New X-Man Cell Lines from Japanese University Mar 31, 2011 EU Provides Horizon Discovery $1.7M to Develop Cancer Models Jan 6, 2011 Horizon Discovery, University of Washington Partner on Gene Editing Technology Nov 2, 2010 Horizon Discovery, Mirna Collaborate on miRNA Mimics Oct 5, 2010 Horizon Discovery Completes Acquisition of Hypoxium, Launches Horizon Discovery Services Sep 28, 2010 Horizon Discovery Raises $9.9M in Series C Financing Sep 9, 2010 Horizon Discovery, UK's ICR in Cancer Target Screening Pact Aug 10, 2010 Horizon Discovery Joins Personalized Medicine Consortium; Gets Grant Apr 12, 2010 TGen, Horizon Discovery Set PGx Pact Jan 5, 2010 Horizon Discovery Launches Companion Dx Subsidiary Oct 27, 2009 Array BioPharma to Use Horizon Discovery's X-MAN Lines Breaking News EliTechGroup Obtains CE Mark for Saliva Use With SARS-CoV-2 Test Waters Q2 Revenues Up 31 Percent FDA Grants EUAs for SARS-CoV-2 Tests From Thermo Fisher, Phase Scientific Myriad Genetics More Than Doubles Quarterly Revenues Pacific Biosciences Acquires Sample Preparation Firm Circulomics Bruker Posts 34 Percent Jump in Q2 Revenues The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.